$928 Million is the total value of Rhenman & Partners Asset Management AB's 85 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 7.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LLY | Buy | LILLY ELI & CO | $53,713,000 | +41.4% | 100,000 | +23.5% | 5.79% | +44.6% |
BSX | Buy | BOSTON SCIENTIFIC CORP | $36,960,000 | +17.8% | 700,000 | +20.7% | 3.98% | +20.5% |
BMRN | BIOMARIN PHARMACEUTICAL INC | $33,622,400 | +2.1% | 380,000 | 0.0% | 3.62% | +4.4% | |
REGN | Buy | REGENERON PHARMACEUTICALS | $32,918,400 | +30.9% | 40,000 | +14.3% | 3.55% | +33.9% |
MCK | MCKESSON CORP | $30,874,350 | +1.8% | 71,000 | 0.0% | 3.33% | +4.1% | |
MDT | Buy | MEDTRONIC PLC | $29,385,000 | +14.2% | 375,000 | +28.4% | 3.17% | +16.8% |
VRTX | Buy | VERTEX PHARMACEUTICALS INC | $26,602,110 | +19.0% | 76,500 | +20.5% | 2.87% | +21.7% |
ABT | Buy | ABBOTT LABS | $25,343,224 | -6.6% | 261,675 | +5.1% | 2.73% | -4.5% |
BDX | BECTON DICKINSON & CO | $24,560,350 | -2.1% | 95,000 | 0.0% | 2.65% | +0.2% | |
HUM | Buy | HUMANA INC | $23,839,480 | +15.9% | 49,000 | +6.5% | 2.57% | +18.5% |
UNH | Sell | UNITED HEALTH GROUP INC | $23,192,740 | -19.6% | 46,000 | -23.3% | 2.50% | -17.7% |
CI | Sell | CIGNA CORP NEW | $22,885,600 | -29.1% | 80,000 | -30.4% | 2.47% | -27.5% |
ABBV | ABBVIE INC | $22,359,000 | +10.6% | 150,000 | 0.0% | 2.41% | +13.2% | |
THC | Buy | TENET HEALTHCARE CORP | $22,073,150 | -6.5% | 335,000 | +15.5% | 2.38% | -4.3% |
ABC | CENCORA INC | $21,416,430 | -6.5% | 119,000 | 0.0% | 2.31% | -4.3% | |
CVS | Buy | CVS HEALTH CORP | $20,946,000 | +22.2% | 300,000 | +21.0% | 2.26% | +25.0% |
HCA | Buy | HCA HEALTHCARE INC | $20,416,340 | +4.3% | 83,000 | +28.7% | 2.20% | +6.7% |
ISRG | Buy | INTUITIVE SURGICAL INC | $19,729,575 | +31.1% | 67,500 | +53.4% | 2.13% | +34.1% |
MRK | MERCK & CO. INC | $19,560,500 | -10.8% | 190,000 | 0.0% | 2.11% | -8.7% | |
COO | Buy | COOPER COS INC | $19,065,000 | -5.8% | 60,000 | +13.6% | 2.06% | -3.7% |
JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $18,591,985 | +3.4% | 143,634 | -0.9% | 2.00% | +5.8% |
GILD | GILEAD SCIENCES INC | $17,535,960 | -2.8% | 234,000 | 0.0% | 1.89% | -0.5% | |
ANTM | Sell | ELEVANCE HEALTH INC | $16,545,960 | -33.5% | 38,000 | -32.1% | 1.78% | -32.0% |
Buy | PROCEPT BIOROBOTICS CORP | $16,175,330 | +64.0% | 493,000 | +76.7% | 1.74% | +67.7% | |
SWAV | Buy | SHOCKWAVE MEDICAL INC | $16,127,100 | +0.9% | 81,000 | +44.6% | 1.74% | +3.2% |
DHR | DANAHER CORPORATION | $14,886,000 | +3.4% | 60,000 | 0.0% | 1.60% | +5.7% | |
BIIB | Sell | BIOGEN INC | $14,521,065 | -21.0% | 56,500 | -12.4% | 1.57% | -19.2% |
AXNX | AXONICS INC | $12,907,600 | +11.2% | 230,000 | 0.0% | 1.39% | +13.7% | |
NTRA | Buy | NATERA INC | $11,804,528 | +21.3% | 266,769 | +33.4% | 1.27% | +24.1% |
LNTH | Buy | LANTHEUS HLDGS INC | $11,672,640 | +39.1% | 168,000 | +68.0% | 1.26% | +42.1% |
IMGN | Sell | IMMUNOGEN INC | $11,109,000 | -21.5% | 700,000 | -6.7% | 1.20% | -19.7% |
EXAS | Sell | EXACT SCIENCES CORP | $10,915,200 | -33.6% | 160,000 | -8.6% | 1.18% | -32.0% |
PRVA | PRIVIA HEALTH GROUP INC | $10,580,000 | -11.9% | 460,000 | 0.0% | 1.14% | -9.9% | |
ALKS | Buy | ALKERMES PLC | $10,363,700 | -5.4% | 370,000 | +5.7% | 1.12% | -3.3% |
DVAX | DYNAVAX TECHNOLOGIES CORP | $10,339,000 | +14.3% | 700,000 | 0.0% | 1.12% | +17.0% | |
IQV | IQVIA HLDGS INC | $9,247,250 | -12.5% | 47,000 | 0.0% | 1.00% | -10.5% | |
CRL | New | CHARLES RIV LABS INTL INC | $8,623,120 | – | 44,000 | +100.0% | 0.93% | – |
ALHC | Buy | ALIGNMENT HEALTHCARE INC | $8,328,000 | +44.8% | 1,200,000 | +20.0% | 0.90% | +48.2% |
APLS | Buy | APELLIS PHARMACEUTICALS INC | $8,178,600 | -52.7% | 215,000 | +13.2% | 0.88% | -51.7% |
ALNY | ALNYLAM PHARMACEUTICALS INC | $7,969,500 | -6.8% | 45,000 | 0.0% | 0.86% | -4.7% | |
MRTX | Buy | MIRATI THERAPEUTICS INC | $7,623,000 | +50.7% | 175,000 | +25.0% | 0.82% | +54.2% |
ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $6,733,200 | -66.5% | 60,000 | -56.5% | 0.73% | -65.7% |
IMVT | Buy | IMMUNOVANT INC | $6,375,082 | +236.1% | 166,061 | +66.1% | 0.69% | +243.5% |
NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $6,138,675 | +62.7% | 54,566 | +36.4% | 0.66% | +66.3% |
KRTX | KARUNA THERAPEUTICS INC | $5,918,150 | -22.0% | 35,000 | 0.0% | 0.64% | -20.2% | |
CYTK | CYTOKINETICS INC | $5,892,000 | -9.7% | 200,000 | 0.0% | 0.64% | -7.7% | |
BNTX | Sell | BIONTECH SEsponsored ads | $5,757,920 | -23.8% | 53,000 | -24.3% | 0.62% | -22.0% |
GKOS | Sell | GLAUKOS CORP | $5,493,250 | -18.8% | 73,000 | -23.2% | 0.59% | -17.0% |
ITCI | INTRA-CELLULAR THERAPIES INC | $4,948,550 | -17.7% | 95,000 | 0.0% | 0.53% | -15.8% | |
VEEV | Sell | VEEVA SYS INC | $4,679,350 | -32.4% | 23,000 | -34.3% | 0.50% | -30.7% |
IMCR | IMMUNOCORE HLDGS PLCads | $4,633,528 | -13.4% | 89,278 | 0.0% | 0.50% | -11.3% | |
XNCR | XENCOR INC | $4,533,750 | -19.3% | 225,000 | 0.0% | 0.49% | -17.4% | |
R1 RCM INC | $4,521,000 | -18.3% | 300,000 | 0.0% | 0.49% | -16.5% | ||
IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $4,322,500 | -27.8% | 950,000 | +11.8% | 0.47% | -26.1% |
OSCR | New | OSCAR HEALTH INCcl a | $4,288,900 | – | 770,000 | +100.0% | 0.46% | – |
DXCM | New | DEXCOM INC | $4,198,500 | – | 45,000 | +100.0% | 0.45% | – |
RVNC | Buy | REVANCE THERAPEUTICS INC | $4,148,458 | +33.3% | 361,679 | +194.0% | 0.45% | +36.3% |
RPRX | ROYALTY PHARMA PLC | $4,071,000 | -11.7% | 150,000 | 0.0% | 0.44% | -9.7% | |
NUVALENT INC | $3,953,926 | +9.0% | 86,011 | 0.0% | 0.43% | +11.5% | ||
EVH | EVOLENT HEALTH INCcl a | $3,948,350 | -10.1% | 145,000 | 0.0% | 0.43% | -8.0% | |
BBIO | BRIDGEBIO PHARMA INC | $3,559,950 | +53.3% | 135,000 | 0.0% | 0.38% | +56.7% | |
WST | WEST PHARMACEUTICAL SVSC INC | $3,376,890 | -1.9% | 9,000 | 0.0% | 0.36% | +0.3% | |
HCAT | HEALTH CATALYST INC | $3,238,400 | -19.0% | 320,000 | 0.0% | 0.35% | -17.3% | |
MRNA | Sell | MODERNA INC | $3,098,700 | -43.3% | 30,000 | -33.3% | 0.33% | -42.0% |
TECH | Sell | BIO-TECHNE CORP | $2,905,228 | -25.1% | 42,680 | -10.1% | 0.31% | -23.5% |
AXSM | AXSOME THERAPEUTICS INC | $2,802,589 | -2.7% | 40,100 | 0.0% | 0.30% | -0.7% | |
TXG | Sell | 10X GENOMICS INC | $2,805,000 | -63.1% | 68,000 | -50.0% | 0.30% | -62.3% |
HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $2,669,903 | -63.9% | 81,474 | -61.2% | 0.29% | -63.0% |
MGTX | MEIRAGTX HLDGS PLC | $2,646,421 | -26.9% | 538,986 | 0.0% | 0.28% | -25.4% | |
OLK | OLINK HLDG ABsponsored ads | $2,448,500 | -21.3% | 166,000 | 0.0% | 0.26% | -19.5% | |
CNC | New | CENTENE CORP DEL | $2,066,400 | – | 30,000 | +100.0% | 0.22% | – |
EW | EDWARDS LIFESCIENCES CORP | $2,009,120 | -26.6% | 29,000 | 0.0% | 0.22% | -24.7% | |
VKTX | VIKING THERAPEUTICS INC | $1,992,600 | -31.7% | 180,000 | 0.0% | 0.22% | -30.2% | |
IGMS | IGM BIOSCIENCES INC | $1,670,000 | -9.5% | 200,000 | 0.0% | 0.18% | -7.7% | |
ARVN | ARVINAS INC | $1,669,400 | -20.9% | 85,000 | 0.0% | 0.18% | -18.9% | |
RLAY | RELAY THERAPEUTICS INC | $1,597,900 | -33.0% | 190,000 | 0.0% | 0.17% | -31.7% | |
NTLA | INTELLIA THERAPEUTICS INC | $1,581,000 | -22.5% | 50,000 | 0.0% | 0.17% | -20.9% | |
INSP | Sell | INSPIRE MED SYS INC | $1,389,080 | -72.2% | 7,000 | -54.5% | 0.15% | -71.5% |
TGTX | Buy | TG THERAPEUTICS INC | $1,337,600 | -2.1% | 160,000 | +190.9% | 0.14% | 0.0% |
INMB | INMUNE BIO INC | $1,219,463 | -24.7% | 178,284 | 0.0% | 0.13% | -23.4% | |
EPIX | ESSA PHARMA INC | $1,101,585 | +14.4% | 356,500 | 0.0% | 0.12% | +17.8% | |
ALLO | ALLOGENE THERAPEUTICS INC | $951,000 | -36.2% | 300,000 | 0.0% | 0.10% | -34.4% | |
OM | Sell | OUTSET MED INC | $544,000 | -92.5% | 50,000 | -84.9% | 0.06% | -92.3% |
MRSN | MERSANA THERAPEUTICS INC | $508,000 | -61.4% | 400,000 | 0.0% | 0.06% | -60.4% | |
TMO | THERMO FISHER SCIENTIFIC INC | $253,085 | -3.0% | 500 | 0.0% | 0.03% | 0.0% | |
RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -253,832 | -100.0% | -0.04% | – |
MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -21,700 | -100.0% | -0.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
ALKERMES PLC | 40 | Q3 2023 | 3.3% |
LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR/A | 2023-11-13 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.